Home002294 • SHE
add
Shenzhen Salubris Pharmaceuticals Co Ltd
Nakaraang pagsara
¥52.42
Sakop ng araw
¥51.80 - ¥53.09
Sakop ng taon
¥29.72 - ¥65.63
Market cap
58.41B CNY
Average na Volume
6.13M
P/E ratio
86.84
Dividend yield
0.95%
Primary exchange
SHE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.11B | 15.85% |
Gastos sa pagpapatakbo | 595.66M | 12.44% |
Net na kita | 215.63M | 30.19% |
Net profit margin | 19.42 | 12.38% |
Kita sa bawat share | — | — |
EBITDA | 325.52M | 20.69% |
Aktuwal na % ng binabayarang buwis | 7.72% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.42B | 26.81% |
Kabuuang asset | 10.98B | 7.34% |
Kabuuang sagutin | 2.05B | 29.25% |
Kabuuang equity | 8.93B | — |
Natitirang share | 1.11B | — |
Presyo para makapag-book | 6.66 | — |
Return on assets | 5.45% | — |
Return on capital | 6.52% | — |
Cash Flow
Net change in cash
| (CNY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 215.63M | 30.19% |
Cash mula sa mga operasyon | 351.03M | 9.40% |
Cash mula sa pag-invest | -236.28M | 55.75% |
Cash mula sa financing | 24.83M | -91.95% |
Net change in cash | 135.42M | 53.56% |
Malayang cash flow | -881.51M | 27.65% |
Tungkol
Shenzhen Salubris Pharmaceuticals is a Chinese pharmaceutical company.
Founded in November 1998 and based in Shenzhen, it has a market cap of US$4.4 billion, 3,121 employees and annual sales of $553 million as of 2019.
Shenzhen Salubris is headed by the billionaire Ye Chenghai. Wikipedia
Itinatag
Nob 3, 1998
Website
Mga Empleyado
3,596
